For all of the above, we propose TH as a noninferiority approach in the management of persons with type 1 diabetes who use classic multiple daily injections insulin therapy with or without FGM attended in a rural area, with fewer in-person visits. The gene discussed is INS; the disease is type 1 diabetes mellitus.